David Planchard Shared Highlights from ESMO Academy 2025
The ESMO Academy 2025 took place in Prague, from 22 to 24 August 2025. The ESMO Academy 2025 offered an in-depth and comprehensive update on critical aspects of medical oncology.
The event covered topics such as the methodology and interpretation of clinical trials, current standards of care, and future developments in major tumor types. It also included discussions on pharmacokinetics and drug interactions.
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared highlights from ESMO Academy 2025 on LinkedIn:
“A year has flown by, and here we go again with ESMO Academy 2025 in Prague! Such a pleasure to be surrounded by my incredible colleagues Raffaele Califano, Jarushka Naidoo for tomorrow’s lung session. Get ready, so many exciting updates ahead! ”
“It is always a great success and a pleasure to be able to speak at ESMO Academy to such a wonderful audience with my lung colleagues.”
“If you want to know everything about the management of metastatic NSCLC and SCLC, check out the ESMO Academy slides/presentation by Raffaele Califano, Jarushka Naidoo, superb coverage of what you need to know in 2025…”
“With targeted therapies and immunotherapy, the progress in treating early-stage NSCLC over the past few years has been impressive, with more and more patients being cured. The remaining goals are prevention and better screening!”
“Thrilled to have a fantastic lung team at ESMO Academy 2025 ! Best of luck to our young oncologists taking the ESMO exams. we hope this provides valuable preparation for your success !”
More post featuring David Planchard on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023